Bahamas vs Croatia: HIV/AIDS deaths averted by antiretroviral therapy
Bahamas
60.36 deaths
in 2024
Croatia
62.42 deaths
in 2024
Bahamas rank
133rd
Croatia rank
132nd
HIV/AIDS deaths averted by antiretroviral therapy over time
- Bahamas
- Croatia
How they compare
Croatia currently reports 62.42 deaths against 60.36 deaths in Bahamas, a difference of 2.06 deaths.
The two have swapped places 2 times across 35 shared years of data; in 1990 it was Croatia ahead.
Bahamas ranks 133rd and Croatia ranks 132nd of 157 countries.
Across the 4 decades both report, Bahamas averaged higher in 3 and Croatia in 1.
Head to head by decade
| Decade | Bahamas | Croatia | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 5.5 deaths | 5.5 deaths | Croatia |
| 2000s | 113.16 deaths | 30.97 deaths | 82.19 deaths | Bahamas |
| 2010s | 136.56 deaths | 54.21 deaths | 82.35 deaths | Bahamas |
| 2020s | 90.13 deaths | 61.72 deaths | 28.42 deaths | Bahamas |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Bahamas or Croatia?
- Croatia, at 62.42 deaths against 60.36 deaths in Bahamas as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Bahamas and Croatia?
- 2.06 deaths, with Croatia ahead.
- How many years of comparable data are there for Bahamas and Croatia?
- 35 years are reported by both, from 1990 to 2024.
- How do Bahamas and Croatia rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Bahamas ranks 133rd and Croatia ranks 132nd of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.